快而精医药 | 41.03 +0.65 +1.61% | ||
| QGEN | |||
| 高 41.10 | 开 39.91 | 量 127.64万股 | 总市值 84.55亿 |
| 低 39.75 | 换 0.62% | 额 5195.47万 | 市盈TTM 19.90 |
分时
5日
日K
周K
月K
季K
年K
快而精医药(QGEN)
03-20 18:05
$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-26-000018 Act: 34 Size: 49 MB 网页链接
快而精医药(QGEN)
03-20 18:05
$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-26-000020 Act: 34 Size: 102 KB 网页链接
快而精医药(QGEN)
02-11 00:25
$快而精医药(QGEN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902219-26-000087 Act: 34 Size: 17 KB 网页链接
快而精医药(QGEN)
02-07 01:15
$快而精医药(QGEN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002012383-26-000897 Act: 34 Size: 11 KB 网页链接
快而精医药(QGEN)
02-06 19:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-26-000003 Act: 34 Size: 483 KB 网页链接
快而精医药(QGEN)
01-10 01:15
$快而精医药(QGEN)$ 25-NSE/A [Amend] Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0000876661-26-000033 Act: 34 Size: 3 KB 网页链接
快而精医药(QGEN)
01-08 22:55
$快而精医药(QGEN)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0000876661-26-000016 Act: 34 Size: 4 KB 网页链接
快而精医药(QGEN)
2025-12-22 19:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000077 Act: 34 Size: 152 KB 网页链接
快而精医药(QGEN)
2025-11-12 22:35
$快而精医药(QGEN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902219-25-000383 Act: 34 Size: 17 KB 网页链接
快而精医药(QGEN)
2025-11-06 19:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000072 Act: 34 Size: 729 KB 网页链接
快而精医药(QGEN)
2025-11-06 19:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000074 Act: 34 Size: 1 MB 网页链接
快而精医药(QGEN)
2025-09-02 18:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000062 Act: 34 Size: 223 KB 网页链接
快而精医药(QGEN)
2025-08-22 05:25
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000057 Act: 34 Size: 1 MB 网页链接
快而精医药(QGEN)
2025-08-16 04:55
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001015820-25-000054 Act: 33 Size: 6 KB 网页链接
快而精医药(QGEN)
2025-08-16 04:35
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-005910 Act: 33 Size: 8 KB 网页链接
快而精医药(QGEN)
2025-08-15 06:15
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-005859 Act: 33 Size: 7 KB 网页链接
快而精医药(QGEN)
2025-08-14 06:15
$快而精医药(QGEN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-005796 Act: 33 Size: 5 KB 网页链接
快而精医药(QGEN)
2025-08-12 22:45
$快而精医药(QGEN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902219-25-000274 Act: 34 Size: 17 KB 网页链接
快而精医药(QGEN)
2025-08-07 18:15
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000049 Act: 34 Size: 497 KB 网页链接
快而精医药(QGEN)
2025-06-30 18:05
$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-25-000044 Act: 34 Size: 145 KB 网页链接